Genpact Reports Full Year and Fourth Quarter 2020 Results
"Our performance during 2020 reflects our agility and culture of embracing change that allowed us to rapidly meet client needs and successfully pivot to new ways of working," said "Tiger" Tyagarajan,
Key Financial Highlights – Full Year 2020
- Total revenue was
$3.7 billion , up 5% year-over-year (6% on a constant currency basis).1 - Revenue from Global Clients was
$3.3 billion , up 7% year-over-year, both on an as reported and constant currency basis1, representing 88% of total revenue. - Revenue from
GE was$459 million , down 4% year-over-year, representing 12% of total revenue. - Net income attributable to
Genpact Limited shareholders was$308 million , up 1% year-over-year, with a corresponding margin of 8.3%. - Income from operations was
$439 million , up 2% year-over-year, with a corresponding margin of 11.8%. Adjusted income from operations was$589 million , up 5% year-over-year, with a corresponding margin of 15.9%.4 - Diluted earnings per share was
$1.57 , up 1% year-over-year, and adjusted diluted earnings per share3 was$2.12 , up 3% year-over-year. - Income from operations and diluted earnings per share include
$26.5 million of restructuring charges related to employee severance costs and lease impairment charges recorded in the second and third quarters of 2020. These restructuring charges are excluded from adjusted income from operations4 and adjusted diluted earnings per share.3 - New bookings were approximately
$3.1 billion , down 20% year-over-year. Global Client new bookings were down 8% year-over-year.5 - Cash generated from operations was
$584 million , up 36% from$428 million in 2019. Genpact repurchased approximately 3.4 million of its common shares for total consideration of approximately$137 million at an average price per share of$40.16 .
Key Financial Highlights – Fourth Quarter 2020
- Total revenue was
$951 million , up 1% year-over-year, both on an as reported and constant currency basis.1 - Revenue from Global Clients was
$841 million , up 4% year-over-year (3% on a constant currency basis)1, representing 89% of total revenue. - Revenue from
GE was$109 million , down 16% year-over-year, representing 11% of total revenue. - Net income was
$75 million , down 9% year-over-year, with a corresponding margin of 7.9%. - Income from operations was
$113 million , down 5% year-over-year, with a corresponding margin of 11.9%. Adjusted income from operations was$148 million , down 7% year-over-year, with a corresponding margin of 15.5%.4 - Diluted earnings per share was
$0.38 , down 10% year-over-year, and adjusted diluted earnings per share3 was$0.51 , down 11% year-over-year. - Cash generated from operations was
$159 million , up 83% from$87 million in the fourth quarter of 2019. Genpact repurchased approximately 1.6 million of its common shares during the quarter for total consideration of approximately$63 million at an average price per share of$38.94 .
Capital Allocation
Genpact's Board of Directors approved a quarterly cash dividend of$0.1075 , a 10% increase, payable onMarch 19, 2021 to shareholders of record as of the close of business onMarch 10, 2021 , and an increase of$500 million to the Company's existing share repurchase authorization.
Full Year 2021 Outlook
- Total revenue of
$3.93 to$3.99 billion , up 6% to 7.5%, or 5.0% to 6.5% on a constant currency basis.1 - Global Client revenue growth in the range of 8.0% to 10%, or 7.0% to 9.0% on a constant currency basis.1
- Adjusted income from operations margin6 of approximately 16.0%.
- Adjusted diluted EPS7 of
$2.26 to$2.29 .
Conference Call to Discuss Financial Results
A live webcast of the call will also be made available on the Genpact Investor Relations website at https://www.genpact.com/investors. For those who cannot join the call live, a replay will be archived on the
About
Safe Harbor
This press release contains certain statements concerning our future growth prospects, including our outlook for 2021, financial results, intention to pay dividends or repurchase our common shares and other forward-looking statements, as defined in the safe harbor provisions of the
Contacts
Investors |
|
|
+1 (203) 808-6725 |
||
Media |
+1 (217) 260-5041 |
GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Balance Sheets (Unaudited) (In thousands, except per share data and share count)
|
||||||||
As of 2019 |
As of 2020 |
|||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ |
467,096 |
$ |
680,440 |
||||
Accounts receivable, net of reserve for doubtful receivables of |
914,255 |
881,020 |
||||||
Prepaid expenses and other current assets |
170,325 |
187,408 |
||||||
Total current assets |
$ |
1,551,676 |
$ |
1,748,868 |
||||
Property, plant and equipment, net |
254,035 |
231,122 |
||||||
Operating lease right-of-use assets |
330,854 |
304,714 |
||||||
Deferred tax assets |
89,715 |
106,674 |
||||||
Intangible assets, net |
230,861 |
236,732 |
||||||
|
1,574,466 |
1,695,688 |
||||||
Contract cost assets |
205,498 |
225,897 |
||||||
Other assets, net of reserve for doubtful assets of |
217,079 |
323,818 |
||||||
Total assets |
$ |
4,454,184 |
$ |
4,873,513 |
||||
Liabilities and equity |
||||||||
Current liabilities |
||||||||
Short-term borrowings |
$ |
70,000 |
$ |
250,000 |
||||
Current portion of long-term debt |
33,509 |
33,537 |
||||||
Accounts payable |
21,981 |
13,910 |
||||||
Income taxes payable |
43,186 |
41,941 |
||||||
Accrued expenses and other current liabilities |
683,871 |
806,769 |
||||||
Operating leases liability |
57,664 |
56,479 |
||||||
Total current liabilities |
$ |
910,211 |
$ |
1,202,636 |
||||
Long-term debt, less current portion |
1,339,796 |
1,307,371 |
||||||
Operating leases liability |
302,100 |
289,363 |
||||||
Deferred tax liabilities |
3,990 |
1,516 |
||||||
Other liabilities |
208,916 |
238,398 |
||||||
Total liabilities |
$ |
2,765,013 |
$ |
3,039,284 |
||||
Shareholders' equity |
||||||||
Preferred shares, |
— |
— |
||||||
Common shares, |
1,896 |
1,885 |
||||||
Additional paid-in capital |
1,570,575 |
1,636,026 |
||||||
Retained earnings |
648,656 |
741,658 |
||||||
Accumulated other comprehensive income (loss) |
(531,956) |
(545,340) |
||||||
Total equity |
$ |
1,689,171 |
$ |
1,834,229 |
||||
Total liabilities and equity |
$ |
4,454,184 |
$ |
4,873,513 |
GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Statements of Income (Unaudited) (In thousands, except per share data and share count)
|
||||||||||||
Three months ended |
||||||||||||
2018 |
2019 |
2020 |
||||||||||
Net revenues |
$ |
835,339 |
$ |
940,739 |
$ |
950,568 |
||||||
Cost of revenue |
533,134 |
630,648 |
613,645 |
|||||||||
Gross profit |
$ |
302,205 |
$ |
310,091 |
$ |
336,923 |
||||||
Operating expenses: |
||||||||||||
Selling, general and administrative expenses |
178,580 |
212,650 |
207,860 |
|||||||||
Amortization of acquired intangible assets |
9,716 |
9,047 |
11,670 |
|||||||||
Other operating (income) expense, net |
3,068 |
(31,124) |
4,340 |
|||||||||
Income from operations |
$ |
110,841 |
$ |
119,518 |
$ |
113,053 |
||||||
Foreign exchange gains (losses), net |
186 |
4,083 |
(4,129) |
|||||||||
Interest income (expense), net |
(9,473) |
(9,971) |
(10,888) |
|||||||||
Other income (expense), net |
5,078 |
719 |
2,292 |
|||||||||
Income before equity-method investment activity, net and |
$ |
106,632 |
$ |
114,349 |
$ |
100,328 |
||||||
Equity-method investment activity, net |
10 |
— |
— |
|||||||||
Income before income tax expense |
$ |
106,642 |
$ |
114,349 |
|
|||||||
Income tax expense |
27,495 |
32,151 |
25,346 |
|||||||||
Net income |
$ |
79,147 |
$ |
82,198 |
$ |
74,982 |
||||||
Net loss (income) attributable to redeemable non-controlling interest |
— |
— |
— |
|||||||||
Net income attributable to |
$ |
79,147 |
$ |
82,198 |
$ |
74,982 |
||||||
Net income available to |
$ |
79,147 |
$ |
82,198 |
$ |
74,982 |
||||||
Earnings per common share attributable to Shareholders |
||||||||||||
Basic |
$ |
0.42 |
$ |
0.43 |
$ |
0.40 |
||||||
Diluted |
$ |
0.41 |
$ |
0.42 |
$ |
0.38 |
||||||
Weighted average number of common shares used in computing |
||||||||||||
Basic |
189,724,744 |
190,083,647 |
189,470,107 |
|||||||||
Diluted |
193,149,836 |
196,592,325 |
194,823,683 |
GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Statements of Income (Unaudited) (In thousands, except per share data and share count)
|
||||||||||||
Year ended |
||||||||||||
2018 |
2019 |
2020 |
||||||||||
Net revenues |
$ |
3,000,790 |
$ |
3,520,543 |
$ |
3,709,377 |
||||||
Cost of revenue |
1,921,768 |
2,294,688 |
2,418,137 |
|||||||||
Gross profit |
$ |
1,079,022 |
$ |
1,225,855 |
$ |
1,291,240 |
||||||
Operating expenses: |
||||||||||||
Selling, general and administrative expenses |
693,865 |
794,901 |
789,849 |
|||||||||
Amortization of acquired intangible assets |
38,850 |
32,612 |
43,343 |
|||||||||
Other operating (income) expense, net |
(1,845) |
(31,034) |
19,331 |
|||||||||
Income from operations |
$ |
348,152 |
$ |
429,376 |
$ |
438,717 |
||||||
Foreign exchange gains (losses), net |
15,239 |
7,729 |
7,482 |
|||||||||
Interest income (expense), net |
(37,119) |
(43,458) |
(48,960) |
|||||||||
Other income (expense), net |
35,761 |
5,786 |
3,238 |
|||||||||
Income before equity-method investment activity, net and |
$ |
362,033 |
$ |
399,433 |
$ |
400,477 |
||||||
Equity-method investment activity, net |
(12) |
(16) |
— |
|||||||||
Income before income tax expense |
$ |
362,021 |
$ |
399,417 |
$ |
400,477 |
||||||
Income tax expense |
80,763 |
94,536 |
92,201 |
|||||||||
Net income |
$ |
281,258 |
$ |
304,881 |
$ |
308,276 |
||||||
Net loss (income) attributable to redeemable non-controlling interest |
761 |
— |
— |
|||||||||
Net income attributable to |
$ |
282,019 |
$ |
304,881 |
$ |
308,276 |
||||||
Net income available to |
$ |
282,019 |
$ |
304,881 |
$ |
308,276 |
||||||
Earnings per common share attributable to shareholders |
||||||||||||
Basic |
$ |
1.48 |
$ |
1.60 |
$ |
1.62 |
||||||
Diluted |
$ |
1.45 |
$ |
1.56 |
$ |
1.57 |
||||||
Weighted average number of common shares used in computing |
||||||||||||
Basic |
190,674,740 |
190,074,475 |
190,396,780 |
|||||||||
Diluted |
193,980,038 |
195,160,855 |
195,780,971 |
GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Statements of Cash Flows (Unaudited) (In thousands)
|
||||||||||||
Year ended |
||||||||||||
2018 |
2019 |
2020 |
||||||||||
Operating activities |
||||||||||||
Net income attributable to |
$ |
282,019 |
$ |
304,881 |
$ |
308,276 |
||||||
Net loss attributable to redeemable non-controlling interest |
(761) |
— |
— |
|||||||||
Net income |
$ |
281,258 |
$ |
304,881 |
$ |
308,276 |
||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||||
Depreciation and amortization |
64,868 |
96,101 |
116,499 |
|||||||||
Amortization of debt issuance costs (including loss on extinguishment of debt) |
3,975 |
1,779 |
2,248 |
|||||||||
Amortization of acquired intangible assets |
38,850 |
32,612 |
43,343 |
|||||||||
Write-down of intangible assets and property, plant and equipment |
4,265 |
3,511 |
14,083 |
|||||||||
Reserve for doubtful receivables/allowance for credit losses |
1,857 |
7,443 |
5,707 |
|||||||||
Unrealized loss (gain) on revaluation of foreign currency asset/liability |
3,352 |
(5,171) |
9,578 |
|||||||||
Stock-based compensation expense |
48,998 |
83,885 |
74,008 |
|||||||||
Deferred tax expense (benefit) |
6,054 |
(16,315) |
(22,587) |
|||||||||
Write-down of operating lease right-of-use assets and other assets |
— |
— |
18,084 |
|||||||||
Gain on exchange of non-monetary asset |
— |
(31,380) |
— |
|||||||||
Others, net |
1,329 |
(2,213) |
(1,291) |
|||||||||
Change in operating assets and liabilities: |
||||||||||||
(Increase) decrease in accounts receivable |
(76,894) |
(121,983) |
42,505 |
|||||||||
Increase in prepaid expenses, other current assets, contract cost assets, |
(76,392) |
(69,813) |
(99,852) |
|||||||||
Increase (decrease) in accounts payable |
26,401 |
(21,375) |
(12,480) |
|||||||||
Increase in accrued expenses, other current liabilities, operating lease liabilities |
5,993 |
157,580 |
87,180 |
|||||||||
Increase (decrease) in income taxes payable |
5,597 |
8,346 |
(993) |
|||||||||
Net cash provided by operating activities |
$ |
339,511 |
$ |
427,888 |
$ |
584,308 |
||||||
Investing activities |
||||||||||||
Purchase of property, plant and equipment |
(84,978) |
(74,927) |
(70,170) |
|||||||||
Payment for internally generated intangible assets (including intangibles under |
(75,439) |
(33,834) |
(10,201) |
|||||||||
Proceeds from sale of property, plant and equipment |
668 |
1,750 |
607 |
|||||||||
Proceeds from sale of equity affiliates |
— |
2,168 |
— |
|||||||||
Payment for business acquisitions, net of cash acquired |
(111,571) |
(252,276) |
(186,633) |
|||||||||
Payment for redeemable non-controlling interest |
(4,730) |
— |
— |
|||||||||
Net cash used for investing activities |
$ |
(276,050) |
$ |
(357,119) |
$ |
(266,397) |
||||||
Financing activities |
||||||||||||
Repayment of capital/finance lease obligations |
(2,395) |
(7,380) |
(10,567) |
|||||||||
Payment of debt issuance costs |
(4,293) |
(2,317) |
(620) |
|||||||||
Proceeds from long-term debt |
129,186 |
400,000 |
— |
|||||||||
Repayment of long-term debt |
(166,186) |
(34,000) |
(34,000) |
|||||||||
Proceeds from short-term borrowings |
250,000 |
400,000 |
610,000 |
|||||||||
Repayment of short-term borrowings |
(125,000) |
(625,000) |
(430,000) |
|||||||||
Proceeds from issuance of common shares under stock-based compensation plans |
14,034 |
19,670 |
25,135 |
|||||||||
Payment for net settlement of stock-based awards |
(15,919) |
(3,850) |
(34,083) |
|||||||||
Payment of earn-out consideration |
(3,356) |
(12,790) |
(6,552) |
|||||||||
Dividend paid |
(57,102) |
(64,671) |
(74,212) |
|||||||||
Payment for stock repurchased and retired (including expenses related to stock |
(154,156) |
(30,015) |
(137,112) |
|||||||||
Net cash provided by/ (used for) financing activities |
$ |
(135,187) |
$ |
39,647 |
$ |
(92,011) |
||||||
Effect of exchange rate changes |
(64,346) |
(11,716) |
(12,556) |
|||||||||
Net increase (decrease) in cash and cash equivalents |
(71,726) |
110,416 |
225,900 |
|||||||||
Cash and cash equivalents at the beginning of the period |
504,468 |
368,396 |
467,096 |
|||||||||
Cash and cash equivalents at the end of the period |
$ |
368,396 |
$ |
467,096 |
$ |
680,440 |
||||||
Supplementary information |
||||||||||||
Cash paid during the period for interest on borrowings (including interest rate swaps) |
$ |
41,484 |
$ |
45,084 |
$ |
49,101 |
||||||
Cash paid during the period for income taxes, net of refunds |
$ |
81,411 |
$ |
104,217 |
$ |
193,946 |
||||||
Property, plant and equipment acquired under capital/finance lease obligations |
$ |
2,031 |
$ |
5,008 |
$ |
29,526 |
||||||
Non-cash transaction: Gain on exchange of non-monetary asset |
$ |
— |
$ |
(31,380) |
$ |
— |
Non-GAAP Financial Measures
To supplement the consolidated financial statements presented in accordance with GAAP, this press release includes the following non-GAAP financial measures:
- Adjusted income from operations;
- Adjusted income from operations margin;
- Adjusted diluted earnings per share; and
- Revenue growth on a constant currency basis.
These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, these non-GAAP financial measures, the financial statements prepared in accordance with GAAP and the reconciliations of
Prior to
Accordingly,
A limitation of using adjusted income from operations and adjusted income from operations margin versus income from operations, income from operations margin, net income and net income margin calculated in accordance with GAAP is that these non-GAAP financial measures exclude certain recurring costs and certain other charges, namely stock-based compensation expense and amortization and impairment of acquired intangible assets. Management compensates for this limitation by providing specific information on the GAAP amounts excluded from adjusted income from operations and adjusted income from operations margin.
The following tables show the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures for the year and three months ended
Reconciliation of Net income attributable to (In thousands)
|
||||||||||||||||
Year ended |
Three months ended |
|||||||||||||||
2019 |
2020 |
2019 |
2020 |
|||||||||||||
Net income attributable to |
$ |
304,881 |
$ |
308,276 |
$ |
82,198 |
$ |
74,982 |
||||||||
Foreign exchange (gains) losses, net |
(7,729) |
(7,482) |
(4,083) |
4,129 |
||||||||||||
Interest (income) expense, net |
43,458 |
48,960 |
9,971 |
10,888 |
||||||||||||
Income tax expense |
94,536 |
92,201 |
32,151 |
25,346 |
||||||||||||
Stock-based compensation expense |
83,885 |
74,008 |
22,579 |
18,190 |
||||||||||||
Amortization and impairment of acquired |
31,458 |
43,648 |
8,768 |
11,430 |
||||||||||||
Restructuring expenses |
- |
26,547 |
- |
- |
||||||||||||
Acquisition-related expenses |
8,352 |
2,650 |
7,385 |
2,650 |
||||||||||||
Adjusted income from operations |
$ |
558,841 |
$ |
588,808 |
$ |
158,969 |
$ |
147,615 |
||||||||
Net income attributable to |
8.7 |
% |
8.3 |
% |
8.7 |
% |
7.9 |
% |
||||||||
Adjusted income from operations margin |
15.9 |
% |
15.9 |
% |
16.9 |
% |
15.5 |
% |
Reconciliation of Income from Operations/Margin to Adjusted Income from Operations/Margin (In thousands)
|
||||||||||||||||
Year ended |
Three months ended |
|||||||||||||||
2019 |
2020 |
2019 |
2020 |
|||||||||||||
Income from operations |
$ |
429,376 |
$ |
438,717 |
$ |
119,518 |
$ |
113,053 |
||||||||
Stock-based compensation expense |
83,885 |
74,008 |
22,579 |
18,190 |
||||||||||||
Amortization and impairment of acquired |
31,458 |
43,648 |
8,768 |
11,430 |
||||||||||||
Acquisition-related expenses |
8,352 |
2,650 |
7,385 |
2,650 |
||||||||||||
Other income (expense), net |
5,786 |
3,238 |
719 |
2,292 |
||||||||||||
Restructuring expenses |
- |
26,547 |
- |
- |
||||||||||||
Equity-method investment activity, net |
(16) |
- |
- |
- |
||||||||||||
Adjusted income from operations |
$ |
558,841 |
$ |
588,808 |
$ |
158,969 |
$ |
147,615 |
||||||||
Income from operations margin |
12.2 |
% |
11.8 |
% |
12.7 |
% |
11.9 |
% |
||||||||
Adjusted income from operations margin |
15.9 |
% |
15.9 |
% |
16.9 |
% |
15.5 |
% |
Reconciliation of Diluted EPS to Adjusted Diluted EPS8 (Per share data)
|
||||||||||||||||
Year ended |
Three months ended |
|||||||||||||||
2019 |
2020 |
2019 |
2020 |
|||||||||||||
Diluted EPS |
$ |
1.56 |
$ |
1.57 |
$ |
0.42 |
$ |
0.38 |
||||||||
Stock-based compensation expense |
0.43 |
0.38 |
0.11 |
0.09 |
||||||||||||
Amortization and impairment of acquired |
0.16 |
0.22 |
0.04 |
0.06 |
||||||||||||
Acquisition-related expenses |
0.04 |
0.01 |
0.04 |
0.01 |
||||||||||||
Restructuring expenses |
- |
0.14 |
- |
- |
||||||||||||
Tax impact on stock-based compensation expense |
(0.10) |
(0.11) |
(0.02) |
(0.03) |
||||||||||||
Tax impact on amortization and impairment of |
(0.04) |
(0.06) |
(0.01) |
(0.01) |
||||||||||||
Tax impact on acquisition-related expenses |
(0.01) |
(0.00) |
(0.01) |
(0.00) |
||||||||||||
Tax impact on restructuring expenses |
- |
(0.03) |
- |
- |
||||||||||||
Adjusted diluted EPS |
$ |
2.05 |
$ |
2.12 |
$ |
0.57 |
$ |
0.51 |
The following tables show the reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures for the year ending
Reconciliation of Outlook for Net income attributable to |
||||
Year ending |
||||
Net income attributable to |
8.8 |
% |
||
Estimated interest (income) expense, net |
1.1 |
% |
||
Estimated income tax expense |
2.8 |
% |
||
Estimated stock-based compensation expense |
1.9 |
% |
||
Estimated amortization of acquired intangible assets |
1.4 |
% |
||
Adjusted income from operations margin |
16.0 |
% |
Reconciliation of Outlook for Income from Operations Margin to Adjusted Income from Operations Margin9 |
||||
Year ending |
||||
Income from operations margin |
12.6 |
% |
||
Estimated stock-based compensation expense |
1.9 |
% |
||
Estimated amortization of acquired intangible assets |
1.4 |
% |
||
Estimated other income (expense), net |
0.1 |
% |
||
Adjusted income from operations margin |
16.0 |
% |
Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS9 (Per share data)
|
||||||||
Year ending |
||||||||
Lower |
Upper |
|||||||
Diluted EPS |
$ |
1.77 |
1.80 |
|||||
Estimated stock-based compensation expense |
0.38 |
0.38 |
||||||
Estimated amortization of acquired intangible assets |
0.29 |
0.29 |
||||||
Estimated tax impact on stock-based compensation expense |
(0.11) |
(0.11) |
||||||
Estimated tax impact on amortization of acquired intangible assets |
(0.08) |
(0.08) |
||||||
Adjusted diluted EPS |
$ |
2.26 |
2.29 |
1 |
Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period's |
2 |
Both on an as reported and constant currency basis. Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating |
3 |
Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to adjusted diluted earnings per share is |
4 |
Adjusted income from operations and adjusted income from operations margin are non-GAAP measures. Reconciliations of each of GAAP income from |
5 |
New bookings, an operating measure, represents the total contract value of new contracts and certain renewals, extensions and changes to existing |
6 |
Adjusted income from operations margin is a non-GAAP measure. A reconciliation of the outlook for each of GAAP income from operations margin and |
7 |
Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of the outlook for GAAP diluted earnings per share to adjusted diluted |
8 |
Due to rounding, the numbers presented in this table may not add up precisely to the totals provided. |
9 |
Due to rounding, the numbers presented in this table may not add up precisely to the totals provided. |
View original content to download multimedia:http://www.prnewswire.com/news-releases/genpact-reports-full-year-and-fourth-quarter-2020-results-301225329.html
SOURCE